Earnings Per Share, Diluted of INFINITY PHARMACEUTICALS, INC. from 30 Sep 2011 to 30 Jun 2023
- Taxonomy & unit
- us-gaap: USD/shares
- Description
- The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
- Summary
-
INFINITY PHARMACEUTICALS, INC. quarterly and annual Earnings Per Share, Diluted in USD/shares history and change rate from 30 Sep 2011 to 30 Jun 2023.
- INFINITY PHARMACEUTICALS, INC. Earnings Per Share, Diluted for the quarter ending 30 Jun 2023 was -0.11, a 15% increase year-over-year.
- INFINITY PHARMACEUTICALS, INC. Earnings Per Share, Diluted for the twelve months ending 30 Jun 2023 was 0, a 12% increase year-over-year.
- INFINITY PHARMACEUTICALS, INC. annual Earnings Per Share, Diluted for 2022 was -0.5, a 5.7% increase from 2021.
- INFINITY PHARMACEUTICALS, INC. annual Earnings Per Share, Diluted for 2021 was -0.53, a 22% increase from 2020.
- Source SEC data
- View on sec.gov
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)
INFINITY PHARMACEUTICALS, INC. Quarterly Earnings Per Share, Diluted (USD/shares)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2023 | 0 | -0.11 | +0.02 | +15% | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 10 Aug 2023 | 2023 | Q2 |
| Q1 2023 | 0 | -0.12 | +0.02 | +14% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 09 May 2023 | 2023 | Q1 |
| Q4 2022 | -1 | -0.11 | +0.02 | +15% | 01 Oct 2022 | 31 Dec 2022 | 10-K | 28 Mar 2023 | 2022 | FY |
| Q3 2022 | -1 | -0.12 | 0 | 0% | 01 Jul 2022 | 30 Sep 2022 | 10-Q | 14 Nov 2022 | 2022 | Q3 |
| Q2 2022 | -1 | -0.13 | 0 | 0% | 01 Apr 2022 | 30 Jun 2022 | 10-Q | 10 Aug 2023 | 2023 | Q2 |
| Q1 2022 | -1 | -0.14 | +0.01 | +6.7% | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 09 May 2023 | 2023 | Q1 |
| Q4 2021 | -1 | -0.13 | 01 Oct 2021 | 31 Dec 2021 | 10-K | 28 Mar 2023 | 2022 | FY | ||
| Q3 2021 | -0.12 | +0.04 | +25% | 01 Jul 2021 | 30 Sep 2021 | 10-Q | 14 Nov 2022 | 2022 | Q3 | |
| Q2 2021 | -0.13 | +0.03 | +19% | 01 Apr 2021 | 30 Jun 2021 | 10-Q | 09 Aug 2022 | 2022 | Q2 | |
| Q1 2021 | -0.15 | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 03 May 2022 | 2022 | Q1 | |||
| Q3 2020 | -0.16 | +0.04 | +20% | 01 Jul 2020 | 30 Sep 2020 | 10-Q | 02 Nov 2021 | 2021 | Q3 | |
| Q2 2020 | -0.16 | 01 Apr 2020 | 30 Jun 2020 | 10-Q | 27 Jul 2021 | 2021 | Q2 | |||
| Q3 2019 | -0.2 | -0.43 | -187% | 01 Jul 2019 | 30 Sep 2019 | 10-Q | 30 Oct 2019 | 2019 | Q3 | |
| Q3 2018 | 0.23 | +0.37 | 01 Jul 2018 | 30 Sep 2018 | 10-Q | 30 Oct 2019 | 2019 | Q3 | ||
| Q3 2017 | -0.14 | +0.25 | +64% | 01 Jul 2017 | 30 Sep 2017 | 10-Q | 05 Nov 2018 | 2018 | Q3 | |
| Q2 2017 | -0.34 | -1.39 | -132% | 01 Apr 2017 | 30 Jun 2017 | 10-Q | 03 Aug 2017 | 2017 | Q2 | |
| Q4 2016 | -1 | -0.46 | +0.34 | +42% | 01 Oct 2016 | 31 Dec 2016 | 10-K | 15 Mar 2018 | 2017 | FY |
| Q3 2016 | -1 | -0.39 | -1.23 | -146% | 01 Jul 2016 | 30 Sep 2016 | 10-K | 15 Mar 2018 | 2017 | FY |
| Q2 2016 | 0 | 1.05 | +1.83 | 01 Apr 2016 | 30 Jun 2016 | 10-K | 15 Mar 2018 | 2017 | FY | |
| Q1 2016 | -2 | -0.82 | +1.09 | +57% | 01 Jan 2016 | 31 Mar 2016 | 10-K | 15 Mar 2018 | 2017 | FY |
| Q4 2015 | -3 | -0.8 | +0.03 | +3.6% | 01 Oct 2015 | 31 Dec 2015 | 10-K | 14 Mar 2017 | 2016 | FY |
| Q3 2015 | -3 | 0.84 | -1.19 | -59% | 01 Jul 2015 | 30 Sep 2015 | 10-K | 14 Mar 2017 | 2016 | FY |
| Q2 2015 | -1 | -0.78 | 0 | 0% | 01 Apr 2015 | 30 Jun 2015 | 10-K | 14 Mar 2017 | 2016 | FY |
| Q1 2015 | -1 | -1.91 | -1.04 | -120% | 01 Jan 2015 | 31 Mar 2015 | 10-K | 14 Mar 2017 | 2016 | FY |
| Q4 2014 | 0 | -0.83 | 01 Oct 2014 | 31 Dec 2014 | 10-K | 23 Feb 2016 | 2015 | FY | ||
| Q3 2014 | 2.03 | +2.74 | 01 Jul 2014 | 30 Sep 2014 | 10-K | 23 Feb 2016 | 2015 | FY | ||
| Q2 2014 | -0.78 | 01 Apr 2014 | 30 Jun 2014 | 10-K | 23 Feb 2016 | 2015 | FY | |||
| Q1 2014 | -0.87 | 01 Jan 2014 | 31 Mar 2014 | 10-K | 23 Feb 2016 | 2015 | FY | |||
| Q3 2013 | -0.71 | -1.23 | -237% | 01 Jul 2013 | 30 Sep 2013 | 10-Q | 10 Nov 2014 | 2014 | Q3 | |
| Q4 2012 | -2 | -1.15 | 01 Oct 2012 | 31 Dec 2012 | 10-K | 25 Feb 2014 | 2013 | FY | ||
| Q3 2012 | 0.52 | +0.97 | 01 Jul 2012 | 30 Sep 2012 | 10-K | 25 Feb 2014 | 2013 | FY | ||
| Q2 2012 | -0.54 | 01 Apr 2012 | 30 Jun 2012 | 10-K | 25 Feb 2014 | 2013 | FY | |||
| Q1 2012 | -0.4 | 01 Jan 2012 | 31 Mar 2012 | 10-K | 25 Feb 2014 | 2013 | FY | |||
| Q3 2011 | -0.45 | 01 Jul 2011 | 30 Sep 2011 | 10-Q | 06 Nov 2012 | 2012 | Q3 |
INFINITY PHARMACEUTICALS, INC. Annual Earnings Per Share, Diluted (USD/shares)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2022 | -0.5 | +0.03 | +5.7% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 28 Mar 2023 | 2022 | FY |
| 2021 | -0.53 | +0.15 | +22% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 28 Mar 2023 | 2022 | FY |
| 2020 | -0.68 | 01 Jan 2020 | 31 Dec 2020 | 10-K | 29 Mar 2022 | 2021 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.